What question did this study set out to answer?

To explore the health and economic impacts of increased beta-blocker utilization in myocardial infarction patients.

December 6, 2000JAMAOpen Access

Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction

View Full Paper

Ask AI

Bookmark

Why the study?

Does increased use of beta-blockers improve clinical outcomes and cost-effectiveness in survivors of myocardial infarction?

Population

Simulated US population of myocardial infarction survivors aged 35 to 84 years

Comparison

Increased use of beta-blockers from current to… vs Current use levels of beta-blockers

Follow-up

20 years (simulated)

Authors

KPKathryn A. PhillipsUniversity of California, San Francisco

Discussion

Member takes

Implication

Highly cost-effective in post-MI modeling; leaves open prospective validation in contemporary cohorts.

Key Points

To explore the health and economic impacts of increased beta-blocker utilization in myocardial infarction patients.
Utilized the Coronary Heart Disease Policy Model for simulations in the US population.
Included a cohort of MI survivors followed for 20 years and annual cohorts of first-MI survivors.
Assessed outcomes such as prevented myocardial infarctions and quality-adjusted life-years gained.
4300 fewer CHD deaths and 3500 MIs prevented with increased beta-blocker use compared to current practices.
An incremental cost per QALY gained of $4500; overall savings of $18 million with widespread implementation.
Restricting beta-blocker therapy reduces potential health impacts significantly by about 60%.

Structured PICO

Does increased use of beta-blockers improve clinical outcomes and cost-effectiveness in survivors of myocardial infarction?

Population

Simulated US population of myocardial infarction (MI) survivors aged 35 to 84 years (1 cohort in 2000 followed for 20 years and 20 successive annual cohorts of first-MI survivors in 2000-2020)

Intervention

Increased use of beta-blockers from current to target levels (all MI survivors except those with absolute contraindications)

Comparator

Current use levels of beta-blockers

Outcome

Prevented MIs, CHD mortality, life-years gained, and cost per quality-adjusted life-year (QALY) gained in 2000-2020hard clinical

Increased use of beta-blockers after MI in eligible patients would lead to substantial gains in health and is highly cost-effective or potentially cost-saving.

Cite This Study

Kathryn A. Phillips (2000) studied this question.

synapsesocial.com/papers/6a1fc9b7c4efe67b78bb4373 https://doi.org/10.1001/jama.284.21.2748

View Full Paper

Ask AI

Bookmark

Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider